Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
(2016) In Annals of Clinical and Translational Neurology 3(1). p.12-20- Abstract
- Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non-AD dementias. Novel and promising CSF biomarkers include neurogranin, a marker of synaptic degeneration, and YKL-40, a marker of neuroinflammation.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8577002
- author
- Janelidze, Shorena LU ; Hertze, Joakim LU ; Zetterberg, Henrik ; Landqvist, Maria LU ; Santillo, Alexander LU ; Blennow, Kaj and Hansson, Oskar LU
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Annals of Clinical and Translational Neurology
- volume
- 3
- issue
- 1
- pages
- 12 - 20
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:26783546
- wos:000368083700002
- pmid:26783546
- scopus:84971453132
- ISSN
- 2328-9503
- DOI
- 10.1002/acn3.266
- language
- English
- LU publication?
- yes
- id
- 4c747963-2326-4523-891e-aa5399ee9c9e (old id 8577002)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26783546?dopt=Abstract
- date added to LUP
- 2016-04-01 13:50:11
- date last changed
- 2022-05-15 07:20:14
@article{4c747963-2326-4523-891e-aa5399ee9c9e, abstract = {{Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non-AD dementias. Novel and promising CSF biomarkers include neurogranin, a marker of synaptic degeneration, and YKL-40, a marker of neuroinflammation.}}, author = {{Janelidze, Shorena and Hertze, Joakim and Zetterberg, Henrik and Landqvist, Maria and Santillo, Alexander and Blennow, Kaj and Hansson, Oskar}}, issn = {{2328-9503}}, language = {{eng}}, number = {{1}}, pages = {{12--20}}, publisher = {{Wiley-Blackwell}}, series = {{Annals of Clinical and Translational Neurology}}, title = {{Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.}}, url = {{http://dx.doi.org/10.1002/acn3.266}}, doi = {{10.1002/acn3.266}}, volume = {{3}}, year = {{2016}}, }